Felix Lai

Felix Lai is an accomplished professional in the field of pharmaceutical development, currently serving as the Vice President of CMC at Nura Bio since May 2025. Prior experiences include positions such as Senior Principal Scientist in Technical Development at Roche and Senior Director of CMC Pharmaceutical Development at Carmot Therapeutics, Inc. Felix has also held several leadership roles at Aligos Therapeutics, Protagonist Therapeutics, and Impax Laboratories, focusing on formulation and process development, product development, and pilot plant operations. Educational background includes a PhD in Chemical Engineering from the University of California, Davis, and a BS in Chemical Engineering from the University of California, Berkeley.